Wednesday, April 22, 2026
wellness India Expo
Home Tags Biopharma

Tag: biopharma

Novel molecules developed to treat Alzheimer’s disease

These non-toxic molecules could be effective in the treatment of the disease

Emcure Pharma launches Emcutix Biopharma to expand dermatology offerings

The focus will be on building a differentiated product portfolio including first-time launches designed to fulfil the unmet needs of the Indian dermatology market

IPA organizes 9th Advanced GMP Workshop 2024

The two-day workshop held virtually featured over 25 distinguished industry leaders, subject matter experts, and global regulators, including USFDA and CDSCO

“Indian vaccine industry has a promising future”

Dr Krishna Ella, Executive Chairman, Bharat Biotech and President, IVMA shares his insights on the industry’s journey so far and the future potential.

CSIR-IMTECH celebrates 83rd CSIR Foundation Day

Dr Sanjeev Khosla, Director, IMTECH felicitating retirees and employees who have completed 25 years of continuous service at CSIR-IMTECH

Illumina introduces the MiSeq i100 Series: its simplest, fastest benchtop sequencers

With room-temperature kit storage and shipping, the company’s newest sequencers remove barriers to enable more insights and discoveries

Indegene Digital Summit: Pharma leaders to drive conversations on GenAI, tech...

With no vendors or booths, the summit continues to facilitate an open exchange of ideas, foster collaboration, and promote thought leadership

BioVoice eMagazine October 2024 | Issue 6 | Volume 5

The Cover Story focuses on the impact of BIOE3 policy. Read Special Interview of Dr Mahesh Bhalgat, Managing Director & Group CEO, Veeda Clinical Research. Expert Insights by Dr Prabhu Vinayagam, Medical Advisor, Orchid AMS and Shashank Avadhani, CEO and Co-founder, Alyve Health. Special stories on MPox virus, AMR and AgriTech.

China’s surge in antibody-drug conjugates positions it as key oncology market,...

ADCs have become a focal point in oncology due to their ability to selectively target cancer cells, resulting in reduced off-target side effects.

CSIR-CDRI Lucknow and Zydus to develop best-in-class drug for CKD induced...

Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets